Literature DB >> 24080254

Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis.

Francesco Ciccia1, Riccardo Alessandro, Aroldo Rizzo, Antonina Accardo-Palumbo, Stefania Raimondo, Francesca Raiata, Giuliana Guggino, AnnaRita Giardina, Giacomo De Leo, Guido Sireci, Giovanni Triolo.   

Abstract

OBJECTIVE: Long-term evolution of subclinical gut inflammation to overt Crohn's disease (CD) has been described in AS patients. The aim of this study was to evaluate macrophage polarization occurring in the inflamed gut of patients with AS.
METHODS: Twenty-seven HLA-B27(+) AS patients, 20 CD patients and 17 normal controls were consecutively enrolled. Classic M1 (iNOS(+)IL-10(-)), resolution phase (iNOS(+)IL-10(+)), M2 and CD14(+) macrophages were characterized by immunohistochemistry and flow cytometry. Quantitative gene expression analysis of IFN-γ, IL-4, IL-5, IL-33 and STAT6 was performed by real time PCR.
RESULTS: Classic M1 macrophages were expanded in CD and AS, where resolution phase macrophages predominate. A large increase in CD163(+) (M2) macrophages was observed in AS strictly correlated with the expression of IL-33, a Th2 cytokine involved in M2 polarization. Unlike in CD, CD14(+) macrophages were virtually absent in the gut of AS patients and controls.
CONCLUSION: The absence of CD14(+) macrophages together with the expansion of resolution phase and M2 macrophages is the immunological signature of subclinical ileal inflammation in AS.

Entities:  

Keywords:  M1 macrophages; M2 macrophages; ankylosing spondylitis; gut inflammation; interleukin 33; resolution phase macrophages

Mesh:

Substances:

Year:  2013        PMID: 24080254     DOI: 10.1093/rheumatology/ket323

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  20 in total

Review 1.  Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis.

Authors:  Eric Gracey; Lars Vereecke; Dermot McGovern; Mareike Fröhling; Georg Schett; Silvio Danese; Martine De Vos; Filip Van den Bosch; Dirk Elewaut
Journal:  Nat Rev Rheumatol       Date:  2020-07-13       Impact factor: 20.543

2.  Evidence for M2 macrophage activation in patients with enthesitis-related arthritis category of juvenile idiopathic arthritis.

Authors:  Shruti Bhattacharya; Akhilesh Yadav; Amita Aggarwal
Journal:  Clin Rheumatol       Date:  2019-02-08       Impact factor: 2.980

3.  Collaborative Interferon-γ and Interleukin-17 Signaling Protects the Oral Mucosa from Staphylococcus aureus.

Authors:  Jobert G Barin; Monica V Talor; Julie A Schaub; Nicola L Diny; Xuezhou Hou; Matthew Hoyer; Nathan K Archer; Elizabeth S Gebremariam; Meghan F Davis; Lloyd S Miller; Noel R Rose; Daniela Čiháková
Journal:  Am J Pathol       Date:  2016-07-26       Impact factor: 4.307

4.  The effects of β-D-mannuronic acid (M2000), as a novel NSAID, on COX1 and COX2 activities and gene expression in ankylosing spondylitis patients and the murine monocyte/macrophage, J774 cell line.

Authors:  Fahimeh Jafarnezhad-Ansariha; Mir Saeed Yekaninejad; Ahmad-Reza Jamshidi; Reza Mansouri; Mahdi Vojdanian; Mahdi Mahmoudi; Mohammad Javad Fattahi; Seyed Naser Hashemi; Bernd H A Rehm; Hidenori Matsuo; Emanuela Esposito; Salvatore Cuzzocrea; Abbas Mirshafiey
Journal:  Inflammopharmacology       Date:  2017-08-17       Impact factor: 4.473

Review 5.  Raised incidence of ankylosing spondylitis among Inuit populations could be due to high HLA-B27 association and starch consumption.

Authors:  Taha Rashid; Clyde Wilson; Alan Ebringer
Journal:  Rheumatol Int       Date:  2014-11-11       Impact factor: 2.631

Review 6.  Update on ankylosing spondylitis: current concepts in pathogenesis.

Authors:  Judith A Smith
Journal:  Curr Allergy Asthma Rep       Date:  2015-01       Impact factor: 4.806

Review 7.  Ankylosing spondylitis: an autoimmune or autoinflammatory disease?

Authors:  Daniele Mauro; Ranjeny Thomas; Giuliana Guggino; Rik Lories; Matthew A Brown; Francesco Ciccia
Journal:  Nat Rev Rheumatol       Date:  2021-06-10       Impact factor: 20.543

Review 8.  The Pathogenesis of Ankylosing Spondylitis: an Update.

Authors:  Susanne Juhl Pedersen; Walter P Maksymowych
Journal:  Curr Rheumatol Rep       Date:  2019-11-11       Impact factor: 4.592

9.  Influence of IL10 (rs1800896) Polymorphism and TNF-α, IL-10, IL-17A, and IL-17F Serum Levels in Ankylosing Spondylitis.

Authors:  Matheus Braga; Fernanda Formaggi Lara-Armi; Janisleya Silva Ferreira Neves; Marco Antônio Rocha-Loures; Mariana de Souza Terron-Monich; Larissa Danielle Bahls-Pinto; Quirino Alves de Lima Neto; Joana Maira Valentini Zacarias; Ana Maria Sell; Jeane Eliete Laguila Visentainer
Journal:  Front Immunol       Date:  2021-07-05       Impact factor: 7.561

10.  Islet amyloid with macrophage migration correlates with augmented β-cell deficits in type 2 diabetic patients.

Authors:  Kosuke Kamata; Hiroki Mizukami; Wataru Inaba; Kentaro Tsuboi; Yoshinori Tateishi; Taro Yoshida; Soroku Yagihashi
Journal:  Amyloid       Date:  2014-07-09       Impact factor: 7.141

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.